Karen Krumeich

Karen Krumeich serves as Managing Director at Golden Seeds, LLC since March 2025, focusing on early-stage investments in women-led businesses. Additionally, Karen holds fractional Chief Financial Officer roles for life science companies since March 2024 while previously serving as Chief Financial Officer at Kazia Therapeutics, an oncology-focused firm, from January 2022 to February 2024. Prior roles include Executive Vice President and CFO at Theravectys Inc. and Senior Vice President and CFO at Soligenix, Inc. Karen holds a B.S. in Pharmacy and Accounting from The University of Toledo.